Renaissance BioScience Corp., a global leader in yeast bioengineering, has appointed Dr. James Tansey to its Board of Directors, the company announced July 30. Dr. Tansey is a serial entrepreneur, research academic and business leader with extensive experience in life sciences, technology commercialization, fundraising and corporate governance. He is a Professor at the University of British Columbia's Sauder School of Business and previously taught at Oxford University's Saïd Business School.
Dr. Tansey is also a member of the founding team at Gemina Labs, where he supports fundraising, business development and shareholder strategy. He serves on the boards of dynaCERT Inc. and Vanadium Resources Ltd., and is a Senior Advisor to InBC, British Columbia's $500 million strategic investment fund. His appointment is expected to bolster Renaissance's strategic direction as it focuses on technology platforms of yeast-produced RNA and yeast-derived virus-like particles (VLPs), with initial applications in crop protection and future applications in animal and human health.
Maurice Boucher, Renaissance Co-Founder and Executive Chairman, welcomed Dr. Tansey, stating, 'James brings an outstanding combination of entrepreneurial, strategic and governance experience, together with a strong track record of helping innovative technology companies grow.' Boucher added that Tansey's focus on impact investing and environmental protection fits well with Renaissance's positive environmental impact.
Dr. Tansey commented, 'Renaissance has developed an impressive portfolio of innovative technologies with significant commercial potential across agriculture, industrial biotechnology and animal and human health. I look forward to working with the Board and management team to help the company execute on its growth strategy and create long-term value.'
Dr. John Husnik, Renaissance Co-Founder, Director and CSO, noted that Tansey's experience building companies and securing investment will complement the company's scientific expertise. The appointment comes as Renaissance continues developing and globally commercializing its biotechnology platforms. Based in Vancouver, Canada, Renaissance is a global-leading yeast bioengineering company developing innovative, market-ready, functional microorganisms for agriculture, food, nutrition, and animal and human health. For more information, visit www.renaissancebioscience.com.
